Abamectin is an agrochemical compound registered for pest control that selectively targets biochemical or physiological processes in pest organisms, including acetylcholinesterase inhibition, sodium channel modification, or nicotinic receptor activation. Its mammalian safety margin—defined by the ratio of the mammalian NOAEL to the pesticidal effective dose—is evaluated through a comprehensive regulatory toxicology programme, generating an ADI established by the Joint FAO/WHO Meeting on Pesticide Residues (JMPR). This ADI serves as the starting point for PDE derivation when Abamectin appears as a contaminant impurity in pharmaceutical raw materials of botanical origin.
Occupational exposure monitoring for Abamectin validates that engineering controls achieve the OEL in worker breathing zones during manufacturing, dispensing, and sampling operations. Personal air sampling during representative manufacturing tasks—including powder dispensing, granulation, tableting, and equipment cleaning—provides the primary measu
